SCHEMBL972387

SCHEMBL972387

Cn1cc(C(=O)Nc2ccc(F)cc2Cl)c(C(F)F)n1

nearest known ligand 0.53

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 13/20 0.53
POLB P06746 1/20 0.48
LMNA P02545 1/20 0.47
GRM4 Q14833 1/20 0.46
TP53 P04637 1/20 0.45
THRB P10828 1/20 0.45
SHMT2 P34897 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1145131 0.87 HSD17B10 (0.41) ALOX15LMNATP53
SCHEMBL31375266 0.87 HSD17B10 (0.41) ALOX15LMNATP53
SCHEMBL971255 0.86 ATM (0.50) POLBLMNA
SCHEMBL974151 0.85 CYP1A2 (0.51) POLB
SCHEMBL68043 0.85 CHRM3 (0.51) ALOX15LMNATHRB
SCHEMBL29349968 0.85 CHRM3 (0.51) ALOX15LMNATHRB
SCHEMBL29445383 0.85 CHRM3 (0.51) ALOX15LMNATHRB
SCHEMBL1134849 0.85 CHRM3 (0.49) POLBLMNATHRB
SCHEMBL1136276 0.84 CHRM3 (0.51)
SCHEMBL303047 0.84 CHRM3 (0.51) ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2285779-B1 Method for manufacturing aryl carboxamides BASF SE (DE) 2013-03-27 EP claimed
US-8350046-B2 Method for manufacturing aryl carboxamides BASF SE (DE) 2013-01-08 US claimed
EP-2257530-B1 PROCESS FOR PREPARING SUBSTITUTED BIPHENYLANILIDES BAYER CROPSCIENCE AG (DE) 2011-10-12 EP claimed
CN-102015649-A Method for producing aryl carboxamides BASF SE 2011-04-13 CN claimed
US-20110054183-A1 Method For Manufacturing Aryl Carboxamides BASF SE 2011-03-03 US claimed
EP-2285779-A1 METHOD FOR MANUFACTURING ARYL CARBOXAMIDES BASF SE (DE) 2011-02-23 EP claimed
US-20110003999-A1 Process for Preparing Substituted Biphenylanilides BAYER CROPSCIENCE AG (DE) 2011-01-06 US claimed
EP-2257530-A1 PROCESS FOR PREPARING SUBSTITUTED BIPHENYLANILIDES Bayer CropScience Aktiengesellschaft (DE) 2010-12-08 EP claimed
WO-2009135860-A1 METHOD FOR MANUFACTURING ARYL CARBOXAMIDES BASF SE (DE) 2009-11-12 WO claimed
WO-2009106234-A1 PROCESS FOR PREPARING SUBSTITUTED BIPHENYLANILIDES BAYER CROPSCIENCE AG (DE) 2009-09-03 WO claimed
EP-2093216-A1 Process for preparing substituted biphenylanilides Bayer CropScience AG (DE) 2009-08-26 EP claimed
EP-2300417-B1 PROCESS FOR PREPARING 2-(AMINOMETHYLIDENE)-4,4-DIFLUORO-3-OXOBUTYRIC ESTERS BASF SE (DE) 2015-07-22 EP disclosed
EP-2496560-B1 PROCESS FOR PREPARING 1,3-DISUBSTITUTED PYRAZOLE COMPOUNDS BASF SE (DE) 2015-04-22 EP disclosed
EP-2288597-B1 METHOD FOR PREPARING 1,3,4-SUBSTITUTED PYRAZOL COMPOUNDS BASF SE (DE) 2014-10-29 EP disclosed
EP-2496561-B1 PROCESS FOR PREPARING AMINALE AND THEIR USE FOR PREPARING 1,3-DISUBSTITUTED PYRAZOLE COMPOUNDS BASF SE (DE) 2014-06-04 EP disclosed
WO-2009133178-A1 PROCESS FOR PREPARING 2-(AMINOMETHYLIDENE)-4,4-DIFLUORO-3-OXOBUTYRIC ESTERS BASF SE (DE) 2009-11-05 WO disclosed
WO-2009133179-A2 METHOD FOR THE PRODUCTION OF HALOGEN-SUBSTITUTED 2-(AMINOMETHYLIDENE)-3- OXOBUTYRIC ACID ESTERS BASF SE (DE) 2009-11-05 WO disclosed
WO-2009106234-A1 PROCESS FOR PREPARING SUBSTITUTED BIPHENYLANILIDES BAYER CROPSCIENCE AG (DE) 2009-09-03 WO disclosed
EP-2093216-A1 Process for preparing substituted biphenylanilides Bayer CropScience AG (DE) 2009-08-26 EP disclosed
WO-2008152138-A2 METHOD FOR PRODUCING DIFLUOROMETHYL-SUBSTITUTED PYRAZOLE COMPOUNDS BASF SE (DE) 2008-12-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110054183-A1 Method For Manufacturing Aryl Carboxamides H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR3, CBR1 ALOX15 1963/4885POLB 1691/4885LMNA 2595/4885
US-20110003999-A1 Process for Preparing Substituted Biphenylanilides DDT, PAH, THOP1 ALOX15 2438/4885POLB 425/4885LMNA 3959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.